Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer.

Conti S, Vexler A, Hagoel L, Kalich-Philosoph L, Corn BW, Honig N, Shtraus N, Meir Y, Ron I, Eliaz I, Lev-Ari S.

Integr Cancer Ther. 2018 Jul 25:1534735418790382. doi: 10.1177/1534735418790382. [Epub ahead of print]

PMID:
30043669
2.

Aryl hydrocarbon receptor enhances the expression of miR-150-5p to suppress in prostate cancer progression by regulating MAP3K12.

Yu J, Feng Y, Wang Y, An R.

Arch Biochem Biophys. 2018 Sep 15;654:47-54. doi: 10.1016/j.abb.2018.07.010. Epub 2018 Jul 18.

PMID:
30009782
3.

Oxidized analogs of Di(1H-indol-3-yl)methyl-4-substituted benzenes are NR4A1-dependent UPR inducers with potent and safe anti-cancer activity.

Sanchez M, Xia Z, Rico-Bautista E, Cao X, Cuddy M, Castro DJ, Correa RG, Chen L, Yu J, Bobkov A, Ruvolo V, Andreeff M, Oshima RG, Matsuzawa SI, Reed JC, Zhang XK, Hansel D, Wolf DA, Dawson MI.

Oncotarget. 2018 May 18;9(38):25057-25074. doi: 10.18632/oncotarget.25285. eCollection 2018 May 18.

4.

Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft model.

Draz H, Goldberg AA, Tomlinson Guns ES, Fazli L, Safe S, Sanderson JT.

Invest New Drugs. 2018 Aug;36(4):718-725. doi: 10.1007/s10637-018-0595-8. Epub 2018 Apr 2.

PMID:
29607466
5.

Improvements in Self-reported Lower Urinary Tract Symptoms With Prostate Health Supplement.

Eliaz I, Weil E, Wilk B.

Altern Ther Health Med. 2018 Feb 10. pii: AT5449. [Epub ahead of print]

PMID:
29428929
7.

Diindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase (AMPK).

Draz H, Goldberg AA, Titorenko VI, Tomlinson Guns ES, Safe SH, Sanderson JT.

Cell Signal. 2017 Dec;40:172-182. doi: 10.1016/j.cellsig.2017.09.006. Epub 2017 Sep 18.

PMID:
28923415
8.
9.

MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells.

Li X, Grigalavicius M, Li Y, Li X, Zhong Y, Huang R, Yu D, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z.

Tumour Biol. 2017 Aug;39(8):1010428317713671. doi: 10.1177/1010428317713671.

PMID:
28789597
10.

The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells.

Palomera-Sanchez Z, Watson GW, Wong CP, Beaver LM, Williams DE, Dashwood RH, Ho E.

J Nutr Biochem. 2017 Sep;47:113-119. doi: 10.1016/j.jnutbio.2017.05.005. Epub 2017 May 25.

11.

Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy.

Qu X, Wu Z, Dong W, Zhang T, Wang L, Pang Z, Ma W, Du J.

Oncotarget. 2017 Apr 25;8(17):29501-29518. doi: 10.18632/oncotarget.15704. Review.

12.

Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.

Anota A, Mariet AS, Maingon P, Joly F, Bosset JF, Guizard AV, Bittard H, Velten M, Mercier M.

Health Qual Life Outcomes. 2016 Dec 6;14(1):168.

13.

Recent Advances and Challenges in Studies of Control of Cancer Stem Cells and the Gut Microbiome by the Trametes-Derived Polysaccharopeptide PSP (Review).

Wu JM, Doonan BB, Hsieh TC, Yang Q, Yang XT, Ling MT.

Int J Med Mushrooms. 2016;18(8):651-660. Review.

PMID:
27910783
14.

Regulation of PCGEM1 by p54/nrb in prostate cancer.

Ho TT, Huang J, Zhou N, Zhang Z, Koirala P, Zhou X, Wu F, Ding X, Mo YY.

Sci Rep. 2016 Sep 29;6:34529. doi: 10.1038/srep34529.

15.

Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients.

Hwang C, Sethi S, Heilbrun LK, Gupta NS, Chitale DA, Sakr WA, Menon M, Peabody JO, Smith DW, Sarkar FH, Heath EI.

Am J Transl Res. 2016 Jan 15;8(1):166-76. eCollection 2016.

17.

Comparison of Immunomodulatory and Anticancer Activities in Different Strains of Tremella fuciformis Berk.

Han CK, Chiang HC, Lin CY, Tang CH, Lee H, Huang DD, Zeng YR, Chuang TN, Huang YL.

Am J Chin Med. 2015;43(8):1637-55. doi: 10.1142/S0192415X15500937. Epub 2015 Nov 30.

PMID:
26621447
18.

The Key Role of Mitochondrial Apoptotic Pathway in the Cytotoxic Effect of Mushroom Extracts on Cancer Cells.

Han M, Ling MT, Chen J.

Crit Rev Eukaryot Gene Expr. 2015;25(3):253-8. Review.

PMID:
26558948
19.

Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience.

Li Y, Sarkar FH.

Med Princ Pract. 2016;25 Suppl 2:11-7. doi: 10.1159/000439307. Epub 2015 Oct 27. Review.

20.

Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.

Gee JR, Saltzstein DR, Messing E, Kim K, Kolesar J, Huang W, Havighurst TC, Harris L, Wollmer BW, Jarrard D, House M, Parnes H, Bailey HH.

Eur J Cancer Prev. 2016 Jul;25(4):312-20. doi: 10.1097/CEJ.0000000000000189.

PMID:
26313229

Supplemental Content

Loading ...
Support Center